BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Irvine Pharmaceutical Services, Inc. Completes Successful FDA Inspection


4/17/2012 10:08:01 AM

IRVINE, Calif., April 17, 2012 /PRNewswire/ --Irvine Pharmaceutical Services, a leading provider of cGMP contract development and manufacturing services for the pharmaceutical, biotech, and medical device industries since 1988, is pleased to announce it successfully completed a five day cGMP audit. This comes as a result of Irvine's 24 years ongoing commitment to the highest levels of quality standards.

Dr. Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services commented, "Successfully completing a five day audit with three inspectors in which no Form 483 was issued highlights our keen focus on consistently enhancing our quality systems while expanding our scientific expertise and experience. This endorsement provides our clientele with an even higher level of confidence in our partnership."

The team of FDA investigators performed a thorough and comprehensive audit, reviewing data from areas such as analytical development, analytical quality control, stability storage and testing, analytical development, biopharmaceutical development, structural chemistry, drug delivery device technologies, and microbiology.

Learn more about Irvine at www.irvinepharma.com or meet with members of Irvine's team at the following upcoming meetings: 2012 PDA Annual Meeting, TIDES 2012, 2012 AAPS National Biotechnology Conference, and 2012 BIO International Conference.

About Irvine

Founded in 1988, Irvine Pharmaceutical Services is a premier contract pharmaceutical development organization supporting the pharmaceutical, biopharmaceutical, and medical device industries. Irvine offers complete cGMP pharmaceutical product development support and dedicated project management including services such as analytical method validation and development, biopharmaceutical development, structural chemistry, residual solvents testing, microbiological testing, stability testing and storage, and drug delivery technologies. Irvine's wholly-owned subsidiary, Avrio Biopharma, also supports the industry providing pharmaceutical manufacturing cGMP pharmaceutical formulation, cGMP pharmaceutical development, aseptic filling, and lyophilization services.

Learn more about Irvine by visiting www.irvinepharma.com or by calling 877-445-6554.

SOURCE Irvine Pharmaceutical Services



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES